Zurcher Kantonalbank (Zurich Cantonalbank) - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 231 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$1,160,000
+8.7%
7,673
+4.8%
0.01%
+16.7%
Q2 2022$1,067,000
+13.9%
7,321
-7.4%
0.01%
+20.0%
Q1 2022$937,000
-24.3%
7,905
-11.9%
0.01%
-16.7%
Q4 2021$1,237,000
+64.5%
8,975
+65.8%
0.01%
+50.0%
Q3 2021$752,000
+43.2%
5,4130.0%0.00%
+33.3%
Q2 2021$525,000
+32.9%
5,413
-6.3%
0.00%
+50.0%
Q1 2021$395,000
-32.0%
5,774
-14.9%
0.00%
-50.0%
Q4 2020$581,000
+65.5%
6,782
+25.7%
0.00%
+100.0%
Q3 2020$351,000
-11.1%
5,3970.0%0.00%
-33.3%
Q2 2020$395,000
+240.5%
5,397
+58.5%
0.00%
+200.0%
Q1 2020$116,000
-37.3%
3,4050.0%0.00%0.0%
Q4 2019$185,000
+69.7%
3,405
+30.1%
0.00%0.0%
Q3 2019$109,000
+10.1%
2,618
+16.0%
0.00%0.0%
Q2 2019$99,000
+65.0%
2,256
+94.7%
0.00%0.0%
Q1 2019$60,000
+1.7%
1,159
-27.9%
0.00%0.0%
Q4 2018$59,000
-1.7%
1,6080.0%0.00%0.0%
Q3 2018$60,000
+53.8%
1,608
+62.3%
0.00%
Q2 2018$39,000
+2.6%
991
-32.1%
0.00%
Q1 2018$38,000
-2.6%
1,4590.0%0.00%
Q4 2017$39,0001,4590.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q2 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders